• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威斯康星糖尿病性视网膜病变流行病学研究。第十五部分。黄斑水肿的长期发病率。

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema.

作者信息

Klein R, Klein B E, Moss S E, Cruickshanks K J

机构信息

Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison.

出版信息

Ophthalmology. 1995 Jan;102(1):7-16. doi: 10.1016/s0161-6420(95)31052-4.

DOI:10.1016/s0161-6420(95)31052-4
PMID:7831044
Abstract

BACKGROUND

As part of a population-based study of diabetes mellitus, the incidence of macular edema over a 10-year period and its relation to various risk factors are examined.

METHODS

There were 891 younger-onset people with a diagnosis of having had diabetes before 30 years of age who were taking insulin at baseline examination and 987 older-onset people with a diagnosis of having had diabetes at 30 years of age or older who participated in baseline and 4-year examinations. Of these, 765 younger-onset and 533 older-onset people also participated in a 10-year examination. The presence of macular edema at baseline and follow-up examinations was determined from gradings of stereoscopic fundus photographs.

RESULTS

The incidence of macular edema over the 10-year period was 20.1% in the younger-onset group, 25.4% in the older-onset group taking insulin, and 13.9% in the older-onset group not taking insulin. The incidence of macular edema over the 10-year period was associated with higher levels of glycosylated hemoglobin and more severe retinopathy in both younger- and older-onset groups, and with being female and increased diastolic blood pressure in the older-onset group.

CONCLUSIONS

These data suggest a relatively high incidence of macular edema. The authors' data also suggest that a reduction in hyperglycemia may result in a beneficial decrease in the incidence of macular edema.

摘要

背景

作为一项基于人群的糖尿病研究的一部分,对10年间黄斑水肿的发病率及其与各种危险因素的关系进行了研究。

方法

共有891名在30岁之前被诊断患有糖尿病且在基线检查时使用胰岛素的早发型患者,以及987名在30岁及以上被诊断患有糖尿病且参加了基线检查和4年检查的晚发型患者。其中,765名早发型患者和533名晚发型患者还参加了10年检查。通过立体眼底照片分级确定基线和随访检查时黄斑水肿的情况。

结果

在10年期间,早发型组黄斑水肿的发病率为20.1%,使用胰岛素的晚发型组为25.4%,未使用胰岛素的晚发型组为13.9%。在早发型和晚发型组中,10年期间黄斑水肿的发病率均与糖化血红蛋白水平较高和视网膜病变较严重有关,在晚发型组中还与女性以及舒张压升高有关。

结论

这些数据表明黄斑水肿的发病率相对较高。作者的数据还表明,高血糖的降低可能会使黄斑水肿的发病率有益下降。

相似文献

1
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema.威斯康星糖尿病性视网膜病变流行病学研究。第十五部分。黄斑水肿的长期发病率。
Ophthalmology. 1995 Jan;102(1):7-16. doi: 10.1016/s0161-6420(95)31052-4.
2
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.威斯康星糖尿病视网膜病变流行病学研究:第十七部分。1型糖尿病患者糖尿病视网膜病变的14年发病率、进展情况及相关危险因素
Ophthalmology. 1998 Oct;105(10):1801-15. doi: 10.1016/S0161-6420(98)91020-X.
3
The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema.威斯康星糖尿病视网膜病变流行病学研究。XI. 黄斑水肿的发病率。
Ophthalmology. 1989 Oct;96(10):1501-10. doi: 10.1016/s0161-6420(89)32699-6.
4
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes.威斯康星糖尿病视网膜病变流行病学研究XXIII:1型糖尿病患者黄斑水肿的25年发病率
Ophthalmology. 2009 Mar;116(3):497-503. doi: 10.1016/j.ophtha.2008.10.016. Epub 2009 Jan 22.
5
Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy.高血糖与糖尿病视网膜病变的长期发病率及病情进展的关系。
Arch Intern Med. 1994 Oct 10;154(19):2169-78.
6
Clinically significant macular edema in type I diabetes. Incidence and risk factors.
Ophthalmology. 1995 Aug;102(8):1170-6. doi: 10.1016/s0161-6420(95)30894-9.
7
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.威斯康星糖尿病视网膜病变流行病学研究:XXII 1型糖尿病患者视网膜病变的25年进展情况
Ophthalmology. 2008 Nov;115(11):1859-68. doi: 10.1016/j.ophtha.2008.08.023.
8
Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.氧化型低密度脂蛋白与增殖性糖尿病视网膜病变及由眼底照片确定的临床显著性黄斑水肿的发生率
JAMA Ophthalmol. 2015 Sep;133(9):1054-61. doi: 10.1001/jamaophthalmol.2015.2239.
9
Ten-year incidence of gross proteinuria in people with diabetes.糖尿病患者中大量蛋白尿的十年发病率。
Diabetes. 1995 Aug;44(8):916-23. doi: 10.2337/diab.44.8.916.
10
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy.威斯康星糖尿病视网膜病变流行病学研究。十六、C肽与糖尿病视网膜病变的发病率及进展的关系。
Diabetes. 1995 Jul;44(7):796-801. doi: 10.2337/diab.44.7.796.

引用本文的文献

1
Comparison of the Usefulness of Optical Coherence Tomography Angiography and Fluorescein Angiography in the Diagnosis of Diabetic Macular Edema.光学相干断层扫描血管造影与荧光素血管造影在糖尿病性黄斑水肿诊断中的应用价值比较
Diagnostics (Basel). 2025 Jul 25;15(15):1873. doi: 10.3390/diagnostics15151873.
2
Assessing the Role of Statins as an Adjunctive Anti-VEGF Therapy for Clinically Significant Macular Edema (CSME) in Type 2 Diabetes Mellitus.评估他汀类药物作为2型糖尿病患者临床显著性黄斑水肿(CSME)辅助抗血管内皮生长因子(VEGF)治疗的作用。
Rom J Ophthalmol. 2025 Apr-Jun;69(2):219-227. doi: 10.22336/rjo.2025.35.
3
Serum Apolipoprotein B and B/A1 Ratio as Early Negative Biomarkers for OCT- and OCTA-Detected Retinal Changes in Diabetic Macular Edema.
血清载脂蛋白B及B/A1比值作为糖尿病性黄斑水肿中光学相干断层扫描(OCT)及光学相干断层扫描血管造影(OCTA)检测到的视网膜变化的早期阴性生物标志物
Clin Ophthalmol. 2025 Jul 9;19:2165-2178. doi: 10.2147/OPTH.S527436. eCollection 2025.
4
Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging.使用非侵入性成像技术了解非增殖性糖尿病视网膜病变的进展
Eye (Lond). 2025 Jul 11. doi: 10.1038/s41433-025-03901-3.
5
Association between methylmalonic acid and composite dietary antioxidant index and diabetic retinopathy: data from National Health and Nutrition Examination Survey.甲基丙二酸与复合膳食抗氧化指数和糖尿病视网膜病变之间的关联:来自美国国家健康与营养检查调查的数据
Nutr Metab (Lond). 2025 Jun 3;22(1):54. doi: 10.1186/s12986-025-00953-w.
6
Autonomous Screening for Diabetic Macular Edema Using Deep Learning Processing of Retinal Images.利用视网膜图像的深度学习处理对糖尿病性黄斑水肿进行自主筛查。
Ophthalmol Sci. 2025 Jan 31;5(4):100722. doi: 10.1016/j.xops.2025.100722. eCollection 2025 Jul-Aug.
7
Twenty-Year Trends in Prevalence and Incidence of Diabetic Retinal Disease.糖尿病视网膜病变患病率和发病率的20年趋势
Ophthalmology. 2025 Jul;132(7):767-774. doi: 10.1016/j.ophtha.2025.01.022. Epub 2025 Jan 30.
8
Maculopathies: A Systematic Literature Review on Pathophysiology, Public Health, and Treatment.黄斑病变:关于病理生理学、公共卫生与治疗的系统文献综述
Cureus. 2024 Dec 1;16(12):e74911. doi: 10.7759/cureus.74911. eCollection 2024 Dec.
9
Incidence of Diabetic Retinopathy in Individuals with Type 2 Diabetes: A Study Using Real-World Data.2型糖尿病患者糖尿病视网膜病变的发病率:一项基于真实世界数据的研究。
J Clin Med. 2024 Nov 23;13(23):7083. doi: 10.3390/jcm13237083.
10
One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study.阿柏西普治疗并延长与按需给药方案治疗贝伐单抗耐药性糖尿病性黄斑水肿的一年结局:一项真实世界研究
Ophthalmol Ther. 2025 Jan;14(1):169-181. doi: 10.1007/s40123-024-01067-x. Epub 2024 Nov 22.